Grammatikopoulos Tassos, Sambrotta Melissa, Strautnieks Sandra, Foskett Pierre, Knisely A S, Wagner Bart, Deheragoda Maesha, Starling Chris, Mieli-Vergani Giorgina, Smith Joshua, Bull Laura, Thompson Richard J
Paediatric Liver, GI & Nutrition Centre, King's College Hospital, London, UK; Institute of Liver Studies, Division of Transplantation Immunology and Mucosal Biology, King's College London, London, UK.
Institute of Liver Studies, Division of Transplantation Immunology and Mucosal Biology, King's College London, London, UK.
J Hepatol. 2016 Dec;65(6):1179-1187. doi: 10.1016/j.jhep.2016.07.017. Epub 2016 Jul 25.
BACKGROUND & AIMS: Neonatal sclerosing cholangitis (NSC) is a severe neonatal-onset cholangiopathy commonly leading to liver transplantation (LT) for end-stage liver disease in childhood. Liver biopsy findings histopathologically resemble those in biliary atresia (BA); however, in NSC extrahepatic bile ducts are patent, whilst in BA their lumina are obliterated. NSC is commonly seen in consanguineous kindreds, suggesting autosomal recessive inheritance.
From 29 NSC patients (24 families) identified, DNA was available in 24 (21 families). Thirteen (7 male) patients (12 families) of consanguineous parentage were selected for whole exome sequencing. Sequence variants were filtered for homozygosity, pathogenicity, minor allele frequency, quality score, and encoded protein expression pattern.
Four of 13 patients were homozygous and two were compound heterozygous for mutations in the doublecortin domain containing 2 gene (DCDC2), which encodes DCDC2 protein and is expressed in cholangiocyte cilia. Another 11 patients were sequenced: one (with one sibling pair) was compound heterozygous for DCDC2 mutations. All mutations were protein-truncating. In available liver tissue from patients with DCDC2 mutations, immunostaining for human DCDC2 and the ciliary protein acetylated alpha-tubulin (ACALT) showed no expression (n=6) and transmission electron microscopy found that cholangiocytes lacked primary cilia (n=5). DCDC2 and ACALT were expressed in NSC patients without DCDC2 mutations (n=22). Of the patients carrying DCDC2 mutations, one died awaiting LT; five came to LT, of whom one died 2years later. The other 4 are well.
Among 24 NSC patients with available DNA, 7 had mutations in DCDC2 (6 of 19 families). NSC patients in substantial proportion harbour mutations in DCDC2. Their disease represents a novel liver-based ciliopathy.
Neonatal sclerosing cholangitis (NSC) is a rare genetic form of liver disease presenting in infancy. Through next generation sequencing we identified mutations in the gene encoding for doublecortin domain containing 2 (DCDC2) protein in a group of NSC children. DCDC2 is a signalling and structural protein found in primary cilia of cholangiocytes. Cholangiocytes are the cells forming the biliary system which is the draining system of the liver.
新生儿硬化性胆管炎(NSC)是一种严重的新生儿期发病的胆管病,常导致儿童终末期肝病而需要进行肝移植(LT)。肝活检的组织病理学表现与胆道闭锁(BA)相似;然而,NSC患者肝外胆管通畅,而BA患者胆管腔闭塞。NSC常见于近亲家族,提示常染色体隐性遗传。
从确诊的29例NSC患者(24个家系)中,获取了24例(21个家系)的DNA。选择13例(7例男性)有近亲血缘关系的患者(12个家系)进行全外显子组测序。对序列变异进行纯合性、致病性、次要等位基因频率、质量评分和编码蛋白表达模式的筛选。
13例患者中有4例为双皮质素结构域包含2基因(DCDC2)突变的纯合子,2例为复合杂合子,该基因编码DCDC2蛋白,在胆管细胞纤毛中表达。另外11例患者进行了测序:1例(有1对同胞)为DCDC2突变的复合杂合子。所有突变均导致蛋白截短。在有DCDC2突变患者的可用肝组织中,人DCDC2和纤毛蛋白乙酰化α微管蛋白(ACALT)的免疫染色显示无表达(n = 6),透射电子显微镜发现胆管细胞缺乏初级纤毛(n = 5)。DCDC2和ACALT在无DCDC2突变的NSC患者中表达(n = 22)。携带DCDC2突变的患者中,1例在等待肝移植时死亡;5例接受了肝移植,其中1例在2年后死亡。另外4例情况良好。
在24例有可用DNA的NSC患者中,7例有DCDC2突变(19个家系中的6个)。相当比例的NSC患者存在DCDC2突变。他们的疾病代表一种新的以肝脏为基础的纤毛病。
新生儿硬化性胆管炎(NSC)是一种罕见的婴儿期出现的遗传性肝病。通过下一代测序,我们在一组NSC儿童中发现了编码双皮质素结构域包含2(DCDC2)蛋白的基因突变。DCDC2是一种在胆管细胞初级纤毛中发现的信号和结构蛋白。胆管细胞是构成肝脏引流系统胆道系统的细胞。